From: Hanzakos, Lynn [hanzakol@personalpathsystems.com]
Sent: Friday, May 11, 2001 10:35 AM
To: 'fdadockets@oc.fda.gov'
Subject: Claritin D

PLEASE DO NOT CHANGE THE STATUS OF CLARITIN D FROM PRESCRIPTION TO
OVER-THE-COUNTER! This would cause hardship to millions of us who need to
take it daily and have it paid for by insurance. The insurance companies are
already highly profitable and should not be allowed to benefit from such a
change. Even the over-the-counter price would be more than many of us pay
now in copays. Speaking for my fellow "Baby Boomers" it would be one more
expense that catches us without coverage. We're too young for whatever
Medicare covers and many of our insurance plans have been scaled back
dramatically - from increased premiums, managed care, lower percentage of
coverage, fewer choices and higher costs. Don't add this to the medical
expenses we already suffer!

Lynn Hanzakos
Editor
PersonalPath Systems, Inc.
10 Mountainview Road
Upper Saddle River, NJ 07458
201-512-7265
hanzakol@personalpathsystems.com